Table 5.
Treatment safety evaluation between grous.
| Adverse effect | Patients with q8w/q4w SC (n = 105) | Patients with IV reinduction (n = 23) | p value |
|---|---|---|---|
| Allergy (n/n,%) | 1/105 (1.0) | 1/23 (4.3) | 0.236 |
| Pruritis (n/n,%) | 3/105 (2.9) | 0/23 (0) | 0.414 |
| Total (n/n,%) | 4/105 (3.8) | 1/23 (4.3) | 0.904 |